Logo image of SREA

SEMPRA - SRE 5 3/4 07/01/2079 (SREA) Stock Fundamental Analysis

NYSE:SREA - New York Stock Exchange, Inc. - US8168516040 - Currency: USD

22.02  -0.02 (-0.07%)

Fundamental Rating

3

SREA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 25 industry peers in the Multi-Utilities industry. SREA has a medium profitability rating, but doesn't score so well on its financial health evaluation. SREA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year SREA was profitable.
In the past year SREA had a positive cash flow from operations.
Each year in the past 5 years SREA has been profitable.
Each year in the past 5 years SREA had a positive operating cash flow.
SREA Yearly Net Income VS EBIT VS OCF VS FCFSREA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B

1.2 Ratios

Looking at the Return On Assets, with a value of 2.95%, SREA belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.23%, SREA is in line with its industry, outperforming 52.00% of the companies in the same industry.
SREA has a Return On Invested Capital of 2.83%. This is amonst the worse of the industry: SREA underperforms 92.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SREA is in line with the industry average of 3.89%.
Industry RankSector Rank
ROA 2.95%
ROE 9.23%
ROIC 2.83%
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
SREA Yearly ROA, ROE, ROICSREA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

SREA's Profit Margin of 21.89% is amongst the best of the industry. SREA outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of SREA has grown nicely.
SREA has a better Operating Margin (22.65%) than 72.00% of its industry peers.
SREA's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 22.65%
PM (TTM) 21.89%
GM N/A
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
SREA Yearly Profit, Operating, Gross MarginsSREA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SREA is destroying value.
Compared to 1 year ago, SREA has more shares outstanding
SREA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SREA has a worse debt to assets ratio.
SREA Yearly Shares OutstandingSREA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SREA Yearly Total Debt VS Total AssetsSREA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

SREA has an Altman-Z score of 0.56. This is a bad value and indicates that SREA is not financially healthy and even has some risk of bankruptcy.
SREA's Altman-Z score of 0.56 is on the low side compared to the rest of the industry. SREA is outperformed by 88.00% of its industry peers.
A Debt/Equity ratio of 1.12 is on the high side and indicates that SREA has dependencies on debt financing.
SREA has a better Debt to Equity ratio (1.12) than 88.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACC0.59
WACC4.81%
SREA Yearly LT Debt VS Equity VS FCFSREA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

A Current Ratio of 0.57 indicates that SREA may have some problems paying its short term obligations.
SREA has a Current ratio of 0.57. This is amonst the worse of the industry: SREA underperforms 84.00% of its industry peers.
SREA has a Quick Ratio of 0.57. This is a bad value and indicates that SREA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SREA (0.51) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.51
SREA Yearly Current Assets VS Current LiabilitesSREA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.31% over the past year.
SREA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.31% yearly.
Looking at the last year, SREA shows a very negative growth in Revenue. The Revenue has decreased by -21.14% in the last year.
Measured over the past years, SREA shows a small growth in Revenue. The Revenue has been growing by 4.04% on average per year.
EPS 1Y (TTM)6.31%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%0%
Revenue 1Y (TTM)-21.14%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%-0.37%

3.2 Future

Based on estimates for the next years, SREA will show a small growth in Earnings Per Share. The EPS will grow by 6.81% on average per year.
Based on estimates for the next years, SREA will show a small growth in Revenue. The Revenue will grow by 2.14% on average per year.
EPS Next Y-1.23%
EPS Next 2Y4.57%
EPS Next 3Y5.83%
EPS Next 5Y6.81%
Revenue Next Year-7.81%
Revenue Next 2Y-1.68%
Revenue Next 3Y-0.39%
Revenue Next 5Y2.14%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SREA Yearly Revenue VS EstimatesSREA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
SREA Yearly EPS VS EstimatesSREA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.67 indicates a rather cheap valuation of SREA.
Based on the Price/Earnings ratio, SREA is valued cheaply inside the industry as 88.00% of the companies are valued more expensively.
SREA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.54.
The Price/Forward Earnings ratio is 4.36, which indicates a rather cheap valuation of SREA.
Based on the Price/Forward Earnings ratio, SREA is valued cheaply inside the industry as 88.00% of the companies are valued more expensively.
SREA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.28.
Industry RankSector Rank
PE 4.67
Fwd PE 4.36
SREA Price Earnings VS Forward Price EarningsSREA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

SREA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SREA is cheaper than 68.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.76
SREA Per share dataSREA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.57%
EPS Next 3Y5.83%

3

5. Dividend

5.1 Amount

SREA has a Yearly Dividend Yield of 3.18%. Purely for dividend investing, there may be better candidates out there.
SREA's Dividend Yield is comparable with the industry average which is at 4.09.
Compared to an average S&P500 Dividend Yield of 2.40, SREA pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.18%

5.2 History

The dividend of SREA decreases each year by -9.71%.
SREA has been paying a dividend for over 5 years, so it has already some track record.
SREA has decreased its dividend recently.
Dividend Growth(5Y)-9.71%
Div Incr Years0
Div Non Decr Years1
SREA Yearly Dividends per shareSREA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

SREA pays out 53.42% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP53.42%
EPS Next 2Y4.57%
EPS Next 3Y5.83%
SREA Yearly Income VS Free CF VS DividendSREA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B
SREA Dividend Payout.SREA Dividend Payout, showing the Payout Ratio.SREA Dividend Payout.PayoutRetained Earnings

SEMPRA - SRE 5 3/4 07/01/2079

NYSE:SREA (8/7/2025, 8:04:00 PM)

22.02

-0.02 (-0.07%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners90.23%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap14.36B
Analysts73.64
Price Target22.68 (3%)
Short Float %0%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield 3.18%
Yearly Dividend2.41
Dividend Growth(5Y)-9.71%
DP53.42%
Div Incr Years0
Div Non Decr Years1
Ex-Date06-13 2025-06-13 (0.359375)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.43%
Min EPS beat(2)-7.18%
Max EPS beat(2)8.03%
EPS beat(4)1
Avg EPS beat(4)-5.36%
Min EPS beat(4)-16.27%
Max EPS beat(4)8.03%
EPS beat(8)4
Avg EPS beat(8)-1.23%
EPS beat(12)8
Avg EPS beat(12)2.43%
EPS beat(16)11
Avg EPS beat(16)2.54%
Revenue beat(2)0
Avg Revenue beat(2)-9.28%
Min Revenue beat(2)-14.67%
Max Revenue beat(2)-3.89%
Revenue beat(4)0
Avg Revenue beat(4)-13.33%
Min Revenue beat(4)-22.35%
Max Revenue beat(4)-3.89%
Revenue beat(8)0
Avg Revenue beat(8)-15.32%
Revenue beat(12)3
Avg Revenue beat(12)-3.67%
Revenue beat(16)7
Avg Revenue beat(16)-0.69%
PT rev (1m)3.92%
PT rev (3m)3.2%
EPS NQ rev (1m)-3.58%
EPS NQ rev (3m)2.52%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)-0.05%
Revenue NQ rev (1m)-2.64%
Revenue NQ rev (3m)-4.66%
Revenue NY rev (1m)-0.76%
Revenue NY rev (3m)-4.14%
Valuation
Industry RankSector Rank
PE 4.67
Fwd PE 4.36
P/S 1.08
P/FCF N/A
P/OCF 3.16
P/B 0.45
P/tB 0.48
EV/EBITDA 8.76
EPS(TTM)4.72
EY21.44%
EPS(NY)5.05
Fwd EY22.94%
FCF(TTM)-7.76
FCFYN/A
OCF(TTM)6.96
OCFY31.6%
SpS20.47
BVpS48.55
TBVpS45.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.95%
ROE 9.23%
ROCE 3.39%
ROIC 2.83%
ROICexc 2.89%
ROICexgc 2.95%
OM 22.65%
PM (TTM) 21.89%
GM N/A
FCFM N/A
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
ROICexc(3y)3.32%
ROICexc(5y)3.56%
ROICexgc(3y)3.41%
ROICexgc(5y)3.66%
ROCE(3y)3.99%
ROCE(5y)4.26%
ROICexcg growth 3Y-8.37%
ROICexcg growth 5Y-5.96%
ROICexc growth 3Y-8.1%
ROICexc growth 5Y-5.8%
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF N/A
Debt/EBITDA 6.43
Cap/Depr 386.71%
Cap/Sales 71.94%
Interest Coverage 2.57
Cash Conversion 82.42%
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.51
Altman-Z 0.56
F-Score4
WACC4.81%
ROIC/WACC0.59
Cap/Depr(3y)359.34%
Cap/Depr(5y)353.45%
Cap/Sales(3y)54.96%
Cap/Sales(5y)53.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.31%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%0%
EPS Next Y-1.23%
EPS Next 2Y4.57%
EPS Next 3Y5.83%
EPS Next 5Y6.81%
Revenue 1Y (TTM)-21.14%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%-0.37%
Revenue Next Year-7.81%
Revenue Next 2Y-1.68%
Revenue Next 3Y-0.39%
Revenue Next 5Y2.14%
EBIT growth 1Y1.34%
EBIT growth 3Y1.29%
EBIT growth 5Y1.48%
EBIT Next Year59%
EBIT Next 3Y22.19%
EBIT Next 5Y14.31%
FCF growth 1Y0.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y199.54%
OCF growth 3Y8.5%
OCF growth 5Y9.71%